Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Emily Tsaroucha"'
Autor:
Sofia Mastoraki, Ioanna Balgkouranidou, Emily Tsaroucha, Apostolos Klinakis, Vassilis Georgoulias, Evi Lianidou
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2412-2422 (2021)
MLL3 histone methyltransferase, encoded by the KMT2C gene, is a tumor suppressor that has an essential role in cell‐type‐specific gene expression. We evaluated the prognostic significance of KMT2C promoter methylation as a circulating epigenetic
Externí odkaz:
https://doaj.org/article/ac1d7c9c14a84789a0789d2ca92edcf4
Autor:
Galatea Kallergi, Emmanouil Kontopodis, Aliki Ntzifa, Núria Jordana-Ariza, Niki Karachaliou, Evangelia Pantazaka, Haris A. Charalambous, Amanda Psyrri, Emily Tsaroucha, Ioannis Boukovinas, Anna Koumarianou, Dora Hatzidaki, Evi Lianidou, Vassilis Georgoulias, Rafael Rosell, Athanasios Kotsakis
Publikováno v:
Cancers, Vol 14, Iss 6, p 1574 (2022)
Introduction: Liquid biopsy is a useful tool for monitoring treatment outcome in solid tumors, including lung cancer. The relevance of monitoring CTCs and plasma ctDNA as predictors of clinical outcome was assessed in EGFR-mutant NSCLC patients treat
Externí odkaz:
https://doaj.org/article/1d91e608a7224985ad1d37477d9e5ce6
Autor:
Emily Tsaroucha, Asimina Nikolakopoulou, Georgios Noutsos, Aikaterini Kavvada, Athanasios Andrianopoulos, Athanasios Foteinakopoulos, Aggeliki Rapti
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100200- (2020)
Externí odkaz:
https://doaj.org/article/160cce2dc7014a4cab281673482a212c
Autor:
Konstantinos Tzimopoulos, Katerina Kavvada, Angeliki Rapti, Emily Tsaroucha, Asimina Nikolakopoulou
Publikováno v:
Lung cancer.
Purpose: To investigate the efficacy of metronomic oral vinorelbine versus docetaxel in previously treated patients with advanced non-small-cell lung cancer (NSCLC). Patients and Methods: In this retrospective study,we analyzed the efficacy of oral m
Autor:
Vassilis Georgoulias, Emily Tsaroucha, Apostolos Klinakis, Ioanna Balgkouranidou, Evi Lianidou, Sofia Mastoraki
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 15, Iss 9, Pp 2412-2422 (2021)
Molecular Oncology, Vol 15, Iss 9, Pp 2412-2422 (2021)
Liquid biopsies are emerging noninvasive diagnostic tools in cancer. MLL3 histone methyltransferase is a transcriptional regulator encoded by the tumor suppressor KMT2C gene. We evaluated the prognostic significance of KMT2C epigenetic changes in pla
Autor:
Asimina Nikolakopoulou, Athanasios Foteinakopoulos, Athanasios Andrianopoulos, Aggeliki Rapti, Georgios Noutsos, Aikaterini Kavvada, Emily Tsaroucha
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100200-(2020)
Autor:
Emily Tsaroucha, Georgios Noutsos, Aikaterini Kavvada, Asimina Nikolakopoulou, Ilias Lyroudis, Athanasios Andrianopoulos, Albanis Zannis, Athanasia Athanasopoulou
Publikováno v:
Chest. 156:A239-A240
Autor:
Emily Tsaroucha, Athanasia Athanasopoulou, Aikaterini Kavvada, Asimina Nikolakopoulou, Angeliki Rapti, Athanasios Foteinakopoulos, Kostas Tzimopoulos
Publikováno v:
Chest. 156:A219-A220
Autor:
Emily Tsaroucha, E. Kontopodis, Niki Karachaliou, Ioannis Boukovinas, Panayiotis Katsaounis, Michail Nikolaou, Aliki Ntzifa, Charalambos Haris Charalambous, Vassilis Georgoulias, Amanda Psyrri, Anna Koumarianou, Rafael Rosell, Athanasios Kotsakis, Jordana Nuria, Nikolaos K. Kentepozidis
Publikováno v:
Journal of Clinical Oncology. 37:e20608-e20608
e20608 Background: Osimertinib is an irreversible EGFR tyrosine kinase inhibitor (TKI), selective for EGFR TKI-sensitizing mutations and the T790M resistance mutation. We sought to determine the activity of osimertinib after progression on EGFR TKIs